<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03230994</url>
  </required_header>
  <id_info>
    <org_study_id>CAN201706</org_study_id>
    <nct_id>NCT03230994</nct_id>
  </id_info>
  <brief_title>Cooperative Adenomyosis Network</brief_title>
  <acronym>CAN</acronym>
  <official_title>A Study of Cooperative Network of Diagnosis and Treatment of Uterine Adenomyosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To set up a Cooperative Network by enrolling 5000 patients with Adenomyosis(AM) from multiple
      centers.Based on the Network platform and Database,the investigators try to explore the
      diagnostic strategies for AM and carry out epidemiological survey on the semeiology of AM.In
      addiction，the investigators expect to conduct research on the effect and the follow-up
      fertility outcomes of different medical or surgical treatment, the etiology of AM and
      endometriosis,the perspective investigation of the malignant transformation of AM ;the
      high-risk factors of AM,and finally propel the formation of Expert Consensus and Clinical
      Guidelines about AM which suitable to chinese conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      5000 women diagnosed of Adenomyosis(AM) with pathology, transvaginal ultrasonography or
      magnetic resonance image（MRI）will be enrolled from nationwide multicenters. The investigators
      would build up Network platform, and database with the registered data within 6 months.
      30-month follow-up with an interval of at least once every 6 months will be done for every
      patient ，and update the database timely.

      Based on the Network platform and Database,we try to explore the diagnostic strategies for AM
      and carry out epidemiological survey on the semeiology of AM.In addiction，the investigators
      expect to conduct research on the effect and the follow-up fertility outcomes of different
      medical or surgical treatment,the etiology of AM and endometriosis,the perspective
      investigation of the malignant transformation of AM ;the high-risk factors of AM,and finally
      propel the formation of Expert Consensus and Clinical Guidelines about AM which suitable to
      chinese conditions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Months</target_duration>
  <primary_outcome>
    <measure>Therapeutic effect and Diagnostics</measure>
    <time_frame>2day</time_frame>
    <description>Symptom Assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pathology</measure>
    <time_frame>1day</time_frame>
    <description>Diagnostic assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>selection of therapeutic scheme</measure>
    <time_frame>1day</time_frame>
    <description>pharmacotherapy or surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vision algetic standard（VAS）</measure>
    <time_frame>2day</time_frame>
    <description>Semeiology and evaluative criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>B type ultrasound</measure>
    <time_frame>1day</time_frame>
    <description>Diagnostic assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Magnetic Resonance Imaging</measure>
    <time_frame>1day</time_frame>
    <description>Diagnostic assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pictorial blood loss assessment chart（PBAC）</measure>
    <time_frame>2day</time_frame>
    <description>Semeiology and evaluative criteria</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Dysmenorrhea</condition>
  <condition>Metrorrhagia</condition>
  <condition>Infertility, Female</condition>
  <condition>Pathology</condition>
  <condition>Ultrasonography</condition>
  <condition>Radiography</condition>
  <arm_group>
    <arm_group_label>Different Treatment Groups</arm_group_label>
    <description>Women would receive different pharmacotherapy from the standard approach，such as levonorgestrel-releasing intrauterine system(LNG-IUS)，Gonadotrophin releasing hormone agonist(GnRH-a),surgery,etc.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        5000 women diagnosed of adenomyosis by pathology or magnetic resonance image（MRI）by
        experienced specialist physicians will be enrolled from nationwide multicenter.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women diagnosed of adenomyosis by pathology, transvaginal ultrasound or MRI.

        Exclusion Criteria:

          -  Refusal to join the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Aijun AJ SUN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lei L Li, MD</last_name>
    <phone>139-1198-8831</phone>
    <phone_ext>＋86</phone_ext>
    <email>lileigh@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lei Li</name>
      <address>
        <city>Beijing</city>
        <state>China/Beiing</state>
        <zip>100000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lei L Li, MD</last_name>
      <phone>13911988831</phone>
      <phone_ext>+86</phone_ext>
      <email>lileigh@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Adenomyosis%3A+A+Clinical+Review+of+a+Challenging+Gynecologic+Condition.</url>
    <description>Clinical Challenge</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Adenomyosis%3A+What+the+Patient+Needs.+J+Minim+Invasive+Gynecol.</url>
    <description>Treatment Choices</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Adenomyosis+and+reproductive+performance+after+surgery+for+rectovaginal+and+colorectal+endometriosis%3A+a+systematic+review+and+meta-analysis.</url>
    <description>Fertility Outcome</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/27379972</url>
    <description>Medical Treatment</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/27356477</url>
    <description>ING－IUS</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=Sonography+of+adenomyosis.+J+Ultrasound</url>
    <description>Transvaginal Sonography</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/?term=An+update+on+adenomyosis.+Diagn+Interv+Imaging</url>
    <description>MRI</description>
  </link>
  <reference>
    <citation>Struble J, Reid S, Bedaiwy MA. Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol. 2016 Feb 1;23(2):164-85. doi: 10.1016/j.jmig.2015.09.018. Epub 2015 Sep 30. Review.</citation>
    <PMID>26427702</PMID>
  </reference>
  <reference>
    <citation>Alabiso G, Alio L, Arena S, Barbasetti di Prun A, Bergamini V, Berlanda N, Busacca M, Candiani M, Centini G, Di Cello A, Exacoustos C, Fedele L, Fuggetta E, Gabbi L, Geraci E, Imperiale L, Lavarini E, Incandela D, Lazzeri L, Luisi S, Maiorana A, Maneschi F, Mannini L, Mattei A, Muzii L, Pagliardini L, Perandini A, Perelli F, Pinzauti S, Porpora MG, Remorgida V, Leone Roberti Maggiore U, Seracchioli R, Solima E, Somigliana E, Tosti C, Venturella R, Vercellini P, Viganò P, Vignali M, Zannoni L, Zullo F, Zupi E; Endometriosis Treatment Italian Club. Adenomyosis: What the Patient Needs. J Minim Invasive Gynecol. 2016 May-Jun;23(4):476-88. doi: 10.1016/j.jmig.2015.12.017. Epub 2016 Jan 6. Review.</citation>
    <PMID>26772777</PMID>
  </reference>
  <results_reference>
    <citation>Vercellini P, Consonni D, Barbara G, Buggio L, Frattaruolo MP, Somigliana E. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reprod Biomed Online. 2014 Jun;28(6):704-13. doi: 10.1016/j.rbmo.2014.02.006. Epub 2014 Mar 4. Review.</citation>
    <PMID>24745831</PMID>
  </results_reference>
  <results_reference>
    <citation>Pontis A, D'Alterio MN, Pirarba S, de Angelis C, Tinelli R, Angioni S. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol. 2016 Sep;32(9):696-700. Epub 2016 Jul 5. Review.</citation>
    <PMID>27379972</PMID>
  </results_reference>
  <results_reference>
    <citation>Li L, Leng JH, Shi JH, Zhang JJ, Jia SZ, Li XY, Dai Y, Zhang JR, Li T, Xu XX, Liu ZZ, You SS, Chang XY, Lang JH. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia]. Zhonghua Fu Chan Ke Za Zhi. 2016 Jun 25;51(6):424-30. doi: 10.3760/cma.j.issn.0529-567X.2016.06.005. Chinese.</citation>
    <PMID>27356477</PMID>
  </results_reference>
  <results_reference>
    <citation>Sakhel K, Abuhamad A. Sonography of adenomyosis. J Ultrasound Med. 2012 May;31(5):805-8. Review.</citation>
    <PMID>22535729</PMID>
  </results_reference>
  <results_reference>
    <citation>Levy G, Dehaene A, Laurent N, Lernout M, Collinet P, Lucot JP, Lions C, Poncelet E. An update on adenomyosis. Diagn Interv Imaging. 2013 Jan;94(1):3-25. doi: 10.1016/j.diii.2012.10.012. Epub 2012 Dec 12. Review.</citation>
    <PMID>23246186</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>July 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2017</study_first_posted>
  <last_update_submitted>July 27, 2017</last_update_submitted>
  <last_update_submitted_qc>July 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Aijun Sun</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>adenomyosis</keyword>
  <keyword>diagnosis</keyword>
  <keyword>treatment</keyword>
  <keyword>epidemiology</keyword>
  <keyword>Complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Dysmenorrhea</mesh_term>
    <mesh_term>Adenomyosis</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Metrorrhagia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Network platform, and the website will be attached later.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

